Clearbridge BioMedics, a spin-off company from NUS and MIT, specialises in novel platforms with applications in oncology research ...
Target: S$1,165,000.00
Raised: 100 %
Equity in Exchange: 2.4%
ManukaLife is a Western Australian Manuka development poised to be a global contingent supply delivering low cost and high quality...
Target: S$2,400,000.00
Equity in Exchange: 20%
.png)